Hidden Bibliographic Details
| Other authors / contributors: | Galambos, Louis.
|
|---|
| ISBN: | 0511169310
9780511169311
0511168888
9780511168888
9780511616860
0511616864
9786610436996
6610436991
0521683831
9780521683838
0521864550
9780521864558
1280436999
9781280436994
|
|---|
| Notes: | Includes bibliographical references and index.
Print version record.
|
|---|
| Summary: | Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded.
|
|---|
| Other form: | Print version: Vagelos, P. Roy. Moral corporation. Cambridge ; New York : Cambridge University Press, 2006 0521864550 0521683831
|
|---|
